CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo, J.
Right arrow Articles by Russo, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo, J.
Right arrow Articles by Russo, I. H.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 4 353-364, Copyright © 1994 by American Association for Cancer Research


ARTICLES

Toward a physiological approach to breast cancer prevention

J Russo and IH Russo
Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.

Breast cancer is one of the most frequent malignancies in women, and its incidence is increasing. No reduction in the mortality rate has resulted from advances in early diagnosis and new therapeutic modalities; therefore, new approaches to the understanding of this disease are required. The observation that, in an experimental animal model, full-term pregnancy prior to exposure to a carcinogenic agent protects the mammary gland from malignant transformation led us to study the mechanisms underlying this phenomenon. The protective effect observed after pregnancy did not depend upon gestational or lactational hyperplasia of the mammary gland, but upon structural changes induced in the mammary parenchyma by those processes. Those changes are permanent, since the protective effect is maintained after pregnancy and consists in the complete differentiation of terminal end buds to lobules. The protective effect exerted by pregnancy can be mimicked by treating young virgin rats with a single placental hormone, chorionic gonadotropin. Since the possibility of preventing breast cancer by treating young nulliparous females with hormones that mimic a fullterm pregnancy that results in complete differentiation of the gland is of practical interest to the human female population, we undertook the study of the human breast. The breast of postpubertal nulliparous women is composed of lobular structures reflecting different stages of development. Lobules type 1 (lob 1) are the most undifferentiated ones. Lobules type 2 evolve from the previous ones and have a more complex morphology, being composed of a higher number of ductular structures per lobule. They progress to lobules type 3 and 4, which are present in the pregnant and lactational periods of the mammary gland. In nulliparous women the structure most frequently found at all ages is the lob 1, whereas in parous women, lob 3 is the most frequent one. Lob 1 are considered to be the site of origin of ductal carcinoma in situ, which progresses to invasive carcinoma. Lob 2 originate lobular carcinoma and lob 3 originate adenomas, fibroadenomas, sclerosing adenosis, and apocrine cysts. These observations led us to test if the degree of lobular development influences the transformation of human breast epithelial cells exposed in vitro to chemical carcinogens. We found that primary cultures derived from breast tissues composed of lobules type 1 and 2 express phenotypes of cell transformation which were not observed in cells derived from lobules type 3.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. L. Rock, S. W. Flatt, G. A. Laughlin, E. B. Gold, C. A. Thomson, L. Natarajan, L. A. Jones, B. J. Caan, M. L. Stefanick, R. A. Hajek, et al.
Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Micheli, E. Meneghini, G. Secreto, F. Berrino, E. Venturelli, A. Cavalleri, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, et al.
Plasma Testosterone and Prognosis of Postmenopausal Breast Cancer Patients
J. Clin. Oncol., July 1, 2007; 25(19): 2685 - 2690.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
W F Symmans, D J Fiterman, S K Anderson, M Ayers, R Rouzier, V Dunmire, J Stec, V Valero, N Sneige, C Albarracin, et al.
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding
Endocr. Relat. Cancer, December 1, 2005; 12(4): 1059 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Rowell, D. M. Carpenter, and C. A. Lamartiniere
Chemoprevention of Breast Cancer, Proteomic Discovery of Genistein Action in the Rat Mammary Gland
J. Nutr., December 1, 2005; 135(12): 2953S - 2959S.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Kang, A. Akoum, P. Chapdelaine, P. Laberge, P. E. Poubelle, and M. A. Fortier
Independent regulation of prostaglandins and monocyte chemoattractant protein-1 by interleukin-1{beta} and hCG in human endometrial cells
Hum. Reprod., November 1, 2004; 19(11): 2465 - 2473.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Jernstrom, J. Lubinski, H. T. Lynch, P. Ghadirian, S. Neuhausen, C. Isaacs, B. L. Weber, D. Horsman, B. Rosen, W. D. Foulkes, et al.
Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J Natl Cancer Inst, July 21, 2004; 96(14): 1094 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. C. Rowlands, R. Hakkak, M. J. J. Ronis, and T. M. Badger
Altered Mammary Gland Differentiation and Progesterone Receptor Expression in Rats Fed Soy and Whey Proteins
Toxicol. Sci., November 1, 2002; 70(1): 40 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Z. Jin and R. S. MacDonald
Soy Isoflavones Increase Latency of Spontaneous Mammary Tumors in Mice
J. Nutr., October 1, 2002; 132(10): 3186 - 3190.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. A. Britton, M. D. Gammon, J. B. Schoenberg, J. L. Stanford, R. J. Coates, C. A. Swanson, N. Potischman, K. E. Malone, D. J. Brogan, J. R. Daling, et al.
Risk of Breast Cancer Classified by Joint Estrogen Receptor and Progesterone Receptor Status among Women 20-44 Years of Age
Am. J. Epidemiol., September 15, 2002; 156(6): 507 - 516.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. J. Swerdlow, B. L. De Stavola, B. Floderus, N. V. Holm, J. Kaprio, P. K. Verkasalo, and T. Mack
Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study
J Natl Cancer Inst, August 21, 2002; 94(16): 1238 - 1246.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. A. Wood, J. E. Korkola, and M. C. Archer
Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes
Carcinogenesis, January 1, 2002; 23(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Tryggvadottir, H. Tulinius, J. E. Eyfjord, and T. Sigurvinsson
Breastfeeding and Reduced Risk of Breast Cancer in an Icelandic Cohort Study
Am. J. Epidemiol., July 1, 2001; 154(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Yoshida, H. Eguchi, K. Nakachi, K. Tanimoto, Y. Higashi, K. Suemasu, Y. Iino, Y. Morishita, and S.-i. Hayashi
Distinct mechanisms of loss of estrogen receptor {{alpha}} gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors
Carcinogenesis, December 1, 2000; 21(12): 2193 - 2201.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Davis, C. Kennedy, Y.-E. Chiew, C. L. Clarke, and A. deFazio
Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells
Clin. Cancer Res., November 1, 2000; 6(11): 4334 - 4342.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo
Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal
Human Chorionic Gonadotropin Suppresses Activation of Nuclear Transcription Factor-kappa B and Activator Protein-1 Induced by Tumor Necrosis Factor
J. Biol. Chem., April 28, 2000; 275(18): 13307 - 13314.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Lipworth, L. R. Bailey, and D. Trichopoulos
History of Breast-Feeding in Relation to Breast Cancer Risk: a Review of the Epidemiologic Literature
J Natl Cancer Inst, February 16, 2000; 92(4): 302 - 312.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Gertig, I. E. Stillman, C. Byrne, D. Spiegelman, S. J. Schnitt, J. L. Connolly, G. A. Colditz, and D. J. Hunter
Association of Age and Reproductive Factors with Benign Breast Tissue Composition
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 873 - 879.
[Abstract] [Full Text]


Home page
BMJHome page
A. Szarewski, H. C Kitchener, J. Horowitz, C. Kahlenborn, E. C G Grant, C M. Steel, E. H Price, H. M Anthony, D. Downing, M. J Radcliffe, et al.
Mortality associated with oral contraceptive use
BMJ, August 7, 1999; 319(7206): 386 - 386.
[Full Text]


Home page
CarcinogenesisHome page
J. Yang, K. Yoshizawa, S. Nandi, and A. Tsubura
Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats
Carcinogenesis, April 1, 1999; 20(4): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Z Nikolova, V Djonov, G Zuercher, A. Andres, and A Ziemiecki
Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis
J. Cell Sci., January 9, 1998; 111(18): 2741 - 2751.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.